Jump to content



Recommended Posts

  • 2 weeks later...
  • Replies 48
  • Created
  • Last Reply

Top Posters In This Topic

Some analysts are saying that ORI has reach the potential for its growth, but will remain strong for the foreseeable future.

I have held these for some three years now since near their lows and am impressed with the performance. Anyone comment as to whether they feel that ORI have reached their peek, and whether now would be a good time to sell up and move on?

Link to comment
Share on other sites



ÃÆâ€â„¢ÃƒÆ’ƒâ€Â ÃƒÆ’¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒ¢Ã¢â‚¬Å¾Ã‚¢ÃƒÆ’ƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¢ÃƒÆ’Æâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒâ€¦Ã‚¡ÃƒÆ’‚¬Ãƒâ€Â¦ÃƒÆ’‚¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¬ÃƒÆ’Æâ€â„¢ÃƒÆ’ƒÂ¢Ãƒ¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¢ Nice blue chip with long running uptrend

ÃÆâ€â„¢ÃƒÆ’ƒâ€Â ÃƒÆ’¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒ¢Ã¢â‚¬Å¾Ã‚¢ÃƒÆ’ƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¢ÃƒÆ’Æâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒâ€¦Ã‚¡ÃƒÆ’‚¬Ãƒâ€Â¦ÃƒÆ’‚¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¬ÃƒÆ’Æâ€â„¢ÃƒÆ’ƒÂ¢Ãƒ¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¢ Very small down side on each of the small pull backs

ÃÆâ€â„¢ÃƒÆ’ƒâ€Â ÃƒÆ’¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒ¢Ã¢â‚¬Å¾Ã‚¢ÃƒÆ’ƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¢ÃƒÆ’Æâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒâ€¦Ã‚¡ÃƒÆ’‚¬Ãƒâ€Â¦ÃƒÆ’‚¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¬ÃƒÆ’Æâ€â„¢ÃƒÆ’ƒÂ¢Ãƒ¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¢ Currently bouncing off bottom of trend line, so possible good time to get in.



Financial Stats:



Industry Group Diversified Chemicals

15101020 Shares on Issue 270,057,893


Price (previous close in cents) 1484

Market Cap ($) 4,007,659,132

Earnings (cents per share) 95.7

Price To Earnings 15.51

Dividends (cents per share) 57

Yield (%) 3.84

Asset Backing (cents per share) 313

Price to Assets 4.74





25 Jun 2004 11:08:21 ORI Consumer Products Retail Demand ASXH

25 Jun 2004 11:07:54 Consumer Products Retail Demand PDS

25 Jun 2004 11:04:26 ORI Consumer Products Retail Demand ASXH

25 Jun 2004 11:04:17 Consumer Products Retail Demand PDS

04 Jun 2004 08:53:25 Standard & Poor's Ann: June 04 Qtrly Rebalance to Indices PDS

03 Jun 2004 17:29:15 Appendix 3B - Exercise of options - Exec.Share Option Plan PDS

28 May 2004 11:58:18 ASIC Form 484 PDS

28 May 2004 09:45:21 Appendix 3B - Executive Share Option Plan PDS

26 May 2004 17:45:10 2004 Results Timetable PDS

20 May 2004 10:57:22 Change of Directors Interest Notice PDS

12 May 2004 10:38:44 Change of Directors Interest Notice PDS

11 May 2004 09:10:01 Appendix 3F - Final Share Buy Back Notice PDS

11 May 2004 09:04:00 Daily Share Buy-Back Notice PDS

10 May 2004 09:56:22 Daily Share Buy-Back Notice PDS

07 May 2004 14:06:01 Appendix 3B - Executive Share Option Plan PDS

07 May 2004 09:35:05 Daily Share Buy-Back Notice PDS

06 May 2004 09:16:50 Daily Share Buy-Back Notice PDS

06 May 2004 08:53:44 Daily Share Buy-Back Notice PDS

05 May 2004 09:19:33 Change of Directors Interest Notice PDS







Last Updated 11/06/2004



GICS Sector 15: Materials

GICS Industry Group 1510: Materials

GICS Industry 151010: Chemicals

Head Office 1 Nicholson St, Melbourne, VIC, 3000

Telephone (03) 9665 7111

Facsimile (03) 9665 7937

Website www.orica.com


First Listed 06/09/1938

Balance Date 30 September

AGM 17/12/2003


Dividend Reinvestment? Active (No discount at the current time.)



Orica Limited (ORI) specializes in the manufacture and supply of industrial and

agricultural chemicals, fertilizers, commercial explosives and mining chemicals,

paints and consumer products. Orica's operations are divided into four main

business areas - mining services, chemicals, consumer products and agricultural

chemicals. The Company operates in Europe, the Americas, Asia and Australasia

(approx. 30 countries).


EXPLOSIVES AND BLASTING SERVICES: Orica offers a range of explosives and

blasting technology services to the mining and construction industries. Orica

Explosives' product range can be divided into broad segments such as Initiating

Systems, Ammonium Nitrate, Bulk Explosives, Packaged Explosives and Blasting

Services. On 1/4/2003, Orica acquired 100% ownership of IES Australia, following

the purchase of Ensign Bickford's 30% share for $16million. IES operates in the

manufacture of initiating explosives systems, including detonators, detonating

cord and boosters.


AGRICULTURAL CHEMICALS: Orica Chemicals is Australasia's leading supplier of

industrial and specialty chemicals. Products include chlorine and sodium

hypochlorite for water treatment, plasticisers, caustic soda, raw materials for

surface coatings, adhesives and resins for wood panel boards. The Chemicals

Group is divided into a range of strategic business units. These business units

include Chemnet, ChlorAlkali, Adhesives & Resins, and Mining & Specialty

Chemicals. In September 2003, Orica acquired the Consumer Lawn and Garden

Business in Australia and New Zealand and part of its commercial business in

Australia from Yates Limited (YTL) for $45m.


INCITEC PIVOT LIMITED (70%) : Orica holds a 70% interest in Incitec Pivot

Limited, a manufacturer of nitrogen-based chemicals. IPL was formed through the

merger of Incitec Fertilizers Limited and Pivot Limited and is a supplier of

phosphatic and nitrogenous fertilizer nutrients in east and South Australia.

Incitec brands include BigN, GranAM, Granulokc, SuPerfect and EasyN.


CONSUMER PRODUCTS: Manufactures and distributes paints and paint preparation

products including Dulux and Selleys brands, as well as a range of car care and

lawn and garden care products.





Mr Michael Ernest Beckett

Mr Malcolm W Broomhead

Mr Peter John Benedict Duncan

Mr James Hall

Mr Peter Maxwell Kirby

Mr Graeme R Liebelt

Mr Donald P Mercer

Mr Michael D Tilley

Mrs Catherine Mary Walter


Link to comment
Share on other sites

ORI are a great company and I'm happy to have held them through the bad times. I believe however that they are close to being fully valued, however I could be wrong. CTX is another goer, I'm over the moon with these having bought a substantial amount when they were around 1.50.
Link to comment
Share on other sites

  • 3 weeks later...

Wow! http://www.ShareScene.com/html/emoticons/smile.gif Good profit there Money Mania.


As a technical trader, im looking at the uptrend and seeins no signs of a reversal yet.

I hold happily. http://www.ShareScene.com/html/emoticons/smile.gif





Link to comment
Share on other sites

  • 1 month later...
  • 1 month later...
Tax bombshell rips a hole in Orica
By Ian Porter
October 7, 2004

The Australian Tax Office dropped a bomb on Orica's share price yesterday when it served a tax assessment for $214 million on the chemicals and explosives giant.

Not only was the assessment more than twice the original amount of primary tax assessed; the ATO indicated that Orica might be subjected to a form of double jeopardy if the ATO loses in court.

Investors took fright and dumped Orica shares, sending the price spiralling down as much as 3.2 per cent at one stage.

The shares recovered by the end of trade to close at $17.37 - down 36 ÃÆâ€â„¢ÃƒÆ’ƒâ€Â ÃƒÆ’¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒ¢Ã¢â‚¬Å¾Ã‚¢ÃƒÆ’ƒÆ’¢Ã¢Ã¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒâ€¦Ã‚¡ÃƒÆ’‚¬Ãƒâ€Â¦ÃƒÆ’‚¡ÃƒÆ’Æâ€â„¢ÃƒÆ’ƒÂ¢Ãƒ¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¢, or 2 per cent, for the day.

The total tax assessment was almost double the $95 million figure given in August, although that figure did not include interest and penalties.

Perhaps coincidentally, Orica's market capitalisation was slashed by $97 million on the day, almost equivalent to the increase in the tax demand since the ATO delivered its first assessment.

The dispute with the ATO relates to the forced sale of the company's pharmaceuticals business in 1998 after a decision by ICI plc to sell its 62 per cent Orica stake triggered a buy-out clause in the licence agreement with Zeneca.

Zeneca paid $329 million for the pharmaceuticals operation, which generated a profit of about $300 million for Orica.

The ATO has now increased the primary tax amount of $95 million by adding a 25 per cent penalty - $23.7 million - and interest of $96 million.

"Orica plans to vigorously contest, and lodge an objection against, the amended assessment when received," Orica chief executive Malcolm Broomhead said in a statement.

Mr Broomhead said he expected to reach an agreement with the ATO under which Orica would lodge half the amended assessment, $107 million, with the ATO pending a final resolution.

A spokesman said that would greatly reduce or eliminate the compounding of interest and penalties while the case went through the courts. It was expected to reach court "in a year or two". If Orica won the case, the $107 million would be repaid, with interest.

While the size of the penalties revealed yesterday was a surprise, Orica directors are also believed to have been taken aback by the ATO's statement that it would have a second crack at obtaining the assessed tax and penalties if the first court case failed.

"The ATO has indicated that, if it is unsuccessful in defending the assessment against Orica, it may consider issuing an amended assessment for a similar amount to Orica Australia Pty Ltd, in respect of the same transaction," directors said.

Orica Australia Pty Ltd was the entity that actually owned and sold the pharmaceuticals business.
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

  • Create New...